Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsPolymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients, Published online: 05 October 2018; doi:10.1038/s41397-018-0057-xPolymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

Source: The Pharmacogenomics Journal - October 5, 2018 Category: Drugs & Pharmacology Authors: Luz M. Canet Jose M. S ánchez-Maldonado Rafael C áliz Ana Rodr íguez Ramos Carmen B. Lupia ñez Helena Canh ão Manuel Mart ínez-Bueno Alejandro Escudero Juana Segura-Catena Signe B Sorensen Merete L Hetland Mar ía José Soto-Pino Miguel A. Ferrer An Source Type: research